The PE Ratio as of April 2025 (TTM) for Orphazyme A/S (OZYMF) is -0.04

According to Orphazyme A/S’s latest financial reports and current stock price. The company's current PE Ratio is -0.04. This represents a change of -100.01% compared to the average of 568.17 of the last 4 quarters.

Orphazyme A/S (OZYMF) Historical PE Ratio (quarterly & annually)

How has OZYMF PE Ratio performed in the past?

The mean historical PE Ratio of Orphazyme A/S over the last ten years is -5227.65. The current -0.04 PE Ratio has changed -99.92% with respect to the historical average. Over the past ten years (40 quarters), OZYMF's PE Ratio was at its highest in in the June 2024 quarter at 4.31K. The PE Ratio was at its lowest in in the June 2015 quarter at -8591.97.

Orphazyme A/S (OZYMF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Orphazyme A/S PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Orphazyme A/S (OZYMF) Average PE Ratio

How has OZYMF PE Ratio performed in the past?

The current PE Ratio of Orphazyme A/S (OZYMF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Orphazyme A/S (OZYMF) PE Ratio vs. Peers

How is OZYMF’s PE Ratio compared to its peers?

Orphazyme A/S’s PE Ratio is less than Windtree Therapeutics, Inc. (0), greater than Dermata Therapeutics, Inc. (-10.92), greater than Ensysce Biosciences, Inc. (-0.09), greater than Panbela Therapeutics, Inc. (-0.27), greater than Baudax Bio, Inc. (-0.05), less than Virax Biolabs Group Limited (0), greater than Allarity Therapeutics, Inc. (-0.47), less than ContraFect Corporation (-0.03), less than Avenue Therapeutics, Inc. (-0.00), less than Vaxart, Inc. (-0.02), greater than iBio, Inc. (-10.38), greater than ADMA Biologics, Inc. (-0.42), less than Tonix Pharmaceuticals Holding Corp. (25.49), less than BioCryst Pharmaceuticals, Inc. (-0.00), greater than null (-17.21),

Build a custom stock screener for Orphazyme A/S (OZYMF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orphazyme A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Orphazyme A/S (OZYMF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Orphazyme A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.